Long COVID in Military Organisations
NCT04942249 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2021-06-28
Summary
A prospective, longitudinal cohort study designed to follow-up on 500 Swiss military personnel who tested in 2020 for SARS-CoV-2 (regardless of whether positive or negative, but with a known test result). Participants are invited to undergo an intensive test battery to evaluate if they suffer COVID-19 sequelae. The testing will include evaluation of several body systems (cardio-vascular, pulmonary, neurological, ophthalmological, psychological and general) and male fertility in a voluntary subgroup. Immune markers and SARS-CoV-2 reinfection rates will also be evaluated. The study hypothesis is that SARS-CoV-2 infection causes a multi-system disease with sequelae detectable in a significant proportion of army recruits after infection with SARS-CoV-2.
Conditions
- Covid19
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
Labor Speiz
collaborator UNKNOWN -
Swiss Armed Forces
collaborator OTHER -
Universitatsspital Zurich
collaborator UNKNOWN -
University of Zurich
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-20
- Primary Completion
- 2021-10-31
- Completion
- 2021-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
NCT04503252 ·Status: COMPLETED
-
Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai
NCT05422963 ·Status: UNKNOWN
-
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
NCT05020145 ·Status: COMPLETED
-
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
NCT04659941 ·Status: UNKNOWN ·Phase: PHASE2
-
Immune Response and Risk of Serious Infection to SARS-Cov2
NCT04410432 ·Status: COMPLETED
-
Pharyngeal Carriage Rates and Genetic Typing of Group A Streptococcus and Streptococcus Pneumonia Among Israeli Military Basic Trainees
NCT00808821 ·Status: COMPLETED
-
Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2)
NCT05244330 ·Status: COMPLETED
-
Dysbiosis & Long COVID
NCT06825819 ·Status: RECRUITING
-
Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)
NCT05085522 ·Status: UNKNOWN
-
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
NCT04328441 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)
NCT04625257 ·Status: RECRUITING
-
Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19)
NCT04365322 ·Status: UNKNOWN
-
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.
NCT04362124 ·Status: WITHDRAWN ·Phase: PHASE3
-
Azole-resistance in Aspergillus
NCT03443336 ·Status: COMPLETED
-
MRSA in a Trauma Population: Does Decolonization Prevent Infection?
NCT01820455 ·Status: COMPLETED ·Phase: NA
-
Risks of Bacterial and Fungal Superinfection in Patients With COVID-19
NCT05256316 ·Status: COMPLETED
-
Topical Antibacterial Agents for Prevention of COVID-19
NCT05449392 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Vaccination in Acute COVID-19
NCT05198453 ·Status: COMPLETED
-
Evaluation of NDV-3A Vaccine in Preventing S. Aureus Colonization
NCT03455309 ·Status: COMPLETED ·Phase: PHASE2
-
The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes
NCT04832932 ·Status: ACTIVE_NOT_RECRUITING
-
Bacteriophage Therapy of Difficult-to-treat Infections
NCT05498363 ·Status: COMPLETED
-
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.
NCT04885452 ·Status: COMPLETED
-
Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.
NCT04488484 ·Status: COMPLETED ·Phase: NA
-
Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)
NCT04610515 ·Status: COMPLETED
-
I VACCIN Hospitalization of COVID-19 Patients
NCT05244343 ·Status: COMPLETED